The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]

The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]

Slamet Wardoyo,1 Muhammad Arief Fadillah,2 Hamtini2 1Department of Environmental Health, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia; 2Department of Medical Laboratory Technology, Poltekkes Kemenkes Banten, Tangerang, IndonesiaCorrespondence: Slamet Wardoyo, Tel +62 857 8754 9486, Email slametw...

Full description

Bibliographic Details
Main Authors: Wardoyo S, Fadillah MA, Hamtini
Format: Article
Language:English
Published: Dove Medical Press 2023-12-01
Series:Breast Cancer: Targets and Therapy
Subjects:
breast cancer
endocrine therapy
cdk inhibitors
apoptosis
abemaciclib
Online Access:https://www.dovepress.com/the-potent-novel-cdk46-inhibitor-tqb3616-in-hormone-receptor-positiv-2-peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/the-potent-novel-cdk46-inhibitor-tqb3616-in-hormone-receptor-positiv-2-peer-reviewed-fulltext-article-BCTT

Similar Items